Rehabilitation professionals still are navigating challenges of providing group, concurrent therapies in a world that has come to value individual therapy more
Clinical Briefs for Thursday, August 6
By
Alicia Lasek
Aug 06, 2020
Proposed 9% cuts to therapy ‘potentially devastating’ … Medicare Part D favors generic drugs, say investigators … Novavax finds promising results in coronavirus vaccine trials … Bisphosphonates...
Defining tolerance in therapy
By
Shelly Mesure, MS, OTR/L
Feb 12, 2014
How do you define tolerance? Is tolerance measurable? Is tolerance too subjective? What about activity tolerance? We love to document how patients are improving activity tolerance, but many times that’s...
Medicare tops to-do list for lawmakers
Jan 14, 2008
Legislators are planning to resume discussions about Medicare after passing slimmed-down legislation on this program before the winter recess.
Researchers find holes in antipsychotics’ off-label uses
Jan 09, 2008
Antipsychotic drugs that are used “off-label” for controlling violent behavior in mentally challenged patients are less effective than placebos and dummy pills, according to a new British study.
Are you prepared? 5 questions you need to know the answers to
By
Shelly Mesure, MS, OTR/L
Aug 27, 2013
With all the recent regulatory changes that have come down the line, or are about to, we developed a simple five-question survey that each provider had to ask every therapy employee. If you can develop...